AKT1 and non-small cell lung carcinoma: Thus, inhibiting the expression of let‐7c‐3p could counteract the effect of anwuligan on the survival and proliferation of NSCLC cells and reverse the effect of anwuligan treatment on the phosphorylation of proteins associated with the PI3K/AKT/mTOR signaling pathway.